Physician profile
Fellipe Oliveira
NPI 1598954224
$5,029.11
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $865 · 2020: $392 · 2021: $720 · 2022: $1,007 · 2023: $1,600 · 2024: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,044.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,383.78 | 2019-2024 | |
| Amgen INC. | $781.62 | 2019-2024 | Tavneos, Enbrel, Amjevita |
| Abbvie INC. | $706.05 | 2019-2024 | |
| Pfizer INC. | $448.07 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $284.71 | 2021-2023 | Acthar |
| Lilly USA, LLC | $267.24 | 2019-2023 | Taltz |
| E.R. Squibb & Sons, L.L.C. | $204.45 | 2019-2024 | Orencia |
| Janssen Biotech, INC. | $142.60 | 2019-2024 | Tremfya |
| Glaxosmithkline, LLC. | $137.84 | 2019-2024 | Benlysta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.96 | 2020-2024 | Ofev, Cyltezo |
| Fresenius Kabi USA, LLC | $84.07 | 2023-2024 | Idacio |
| Ucb, INC. | $70.14 | 2019-2024 | Cimzia |
| Sobi, INC | $65.65 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $60.64 | 2021-2023 | Saphnelo |
| Sandoz INC. | $53.15 | 2023-2024 | Hyrimoz |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $48.97 | 2019-2023 | Tymlos |
| Genzyme Corporation | $43.29 | 2019 | |
| Horizon Therapeutics Plc | $40.52 | 2021-2023 | Krystexxa |
| Mallinckrodt Enterprises LLC | $25.72 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.21 | 2023 | Zilretta, Iovera |
| Alvogen INC | $17.46 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.28 | 2021 | |
| Genentech USA, INC. | $12.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fellipe Oliveira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.